Real-World Treatment Study of Koselugo (Selumetinib)

Clinical trial NCT06360406 · RECRUITING

Trial details

NCT number: NCT06360406
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Neurofibromatosis 1 Neurofibroma, Plexiform

Start date: 2024-06-15
Primary completion: 2031-09-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.